Business Wire

Coop Group Extends Blue Yonder Footprint To Enhance Customer-Centric Strategy

23.9.2025 10:00:00 EEST | Business Wire | Press release

Share

Faced with rapidly changing consumer behavior, supply chain disruptions, and inflationary pressures, retailers must make swift decisions to meet customer demand. That’s why the Coop Group, a leading retailer in Switzerland and a current Blue Yonder customer, has expanded its deployment of Blue YonderCategory Management to also include Jumbo, Coop's chain of Do It Yourself (DIY) superstores. This initiative builds upon the company’s existing use of Blue Yonder Category Management within the Coop supermarkets network, which dates back to 2018. The expansion was implemented by Strategix, a Blue Yonder partner.

Coop has a history spanning over 160 years. The retailer began as a small consumer cooperative and is now an international retail and wholesale business. In 2024, Coop recorded revenue of 34.9 billion Swiss Franc (approximately $40 billion USD). With around 97,000 associates, Coop operates through a network of retail formats that include more than 2,400 points of sale, as well as online sales channels.

“Coop acts with a deep sense of responsibility towards its people, regions, and ecosystems, and we are committed to delivering both quality and a diverse range of brands and products we can be proud of,” said Alexander Senft, head of IT Merchandise Management Masterdata, Coop. “Category management excellence is vital for providing value to our customers, which is why we were excited to extend our collaboration with Blue Yonder and Strategix. Expanding the deployment of Blue Yonder Category Management to include Jumbo’s 125 points of sale underscores our dedication to innovation and focus on our demand-driven strategy, ensuring we continue to effectively meet the evolving needs of our customers."

With Blue Yonder Category Management, Coop has achieved a significant milestone in optimizing space planning for its supermarket network, particularly for meat products and fresh bread where the Blue Yonder solution generates approximately 5,700 planograms automatically each year. This innovative space planning solution enables planograms to be tailored to the specific needs of each store while adhering to the requirements of each category. Coop plans to further expand automated planograms into other product groups to further increase efficiency.

Some of the other benefits Coop has seen thanks to Blue Yonder Category Management include:

  • Optimized operations: Coop can quickly optimize available inventory with fully automated processes, allowing category managers to focus on more strategic tasks.
  • Informed decision-making: Coop can make informed choices on product assortment and placement using valuable data-driven insights based on shopper behavior and demand.
  • Enhanced customer experience: Coop can tailor assortments to meet store-specific customer requirements at every point of sale, boosting satisfaction and loyalty through more targeted experiences.
  • Increased profitability and sustainability: Coop can optimize assortments through automated planograms to better align product offerings with consumer preferences to drive sales, reduce waste, and support sustainable practices.

“Thanks to Blue Yonder Category Management, a key advantage of automated planogram creation is the efficient integration of new products into store shelf planning. This capability allows us to plan exactly where new items will be placed and determine the appropriate stock levels for each store. As a result, we can now establish the initial quantities needed for orders, streamlining the introduction of new products across the supply chain. In addition, the solution leverages sales data to optimize product placement and quantity on shelves, enhancing the overall efficiency and value of the stocking process,” said Senft.

"We take pride in our long-term collaboration with the Coop Group and are excited they chose to extend their category management footprint for their DIY division with us,” said Fredrik Prada, vice president, Retail – EMEA, Blue Yonder. “Our Category Management solution provides Coop with the necessary speed and agility to keep up with customer demand and constant industry changes so they can stay ahead of their competition and meet business goals.”

Additional Resources:

About Coop Group

The Coop Group operates in the retail as well as wholesale and production sectors. In the retail sector, Coop operates supermarkets and various specialist formats in Switzerland. The Coop Group is the market leader in many of these formats. In wholesale, the Coop Group operates in Germany, Poland, Romania, Spain, France, Austria and Switzerland through Transgourmet. In the production sector, the internationally active Bell Food Group is the biggest company in the Coop Group. In addition to the Bell Food Group, the Coop Group also operates other manufacturing companies in Switzerland.

The Coop Group can look back on a history of over 160 years and has always been structured along cooperative lines. At the organizational level, it is divided into six regions and has some 2.59 million cooperative members. For the Coop Group, the focus is on the customers. The company gears all its efforts to their needs. As a cooperative, the Coop Group does not strive to maximize profits and reinvests its profits in the company, e.g. in lower prices or its commitment to sustainability. This enables it to plan and invest sustainably over the long term.

About Strategix

Strategix is a boutique consulting company that has implemented most space and category management solutions and processes within Central and Eastern Europe for the past 20 years. Recognized as the Best Category Management Consulting Firm in 2021, Strategix provides highly qualified expertise thanks to its consultants' tenures averaging over ten years. Strategix works closely with 15 of the top 30 retailers in Europe. In addition, its one-stop consulting shop provides customers with system implementation and integration, training and a mobile application to secure the last mile in Category Management. In 2024 and 2025 Strategix has received the Top Service Award by the German Institute for Digitization and Sustainability. https://www.strategix.de/en/

About Blue Yonder

Blue Yonder is the AI company for supply chain. As the world leader in end-to-end digital supply chain transformation, Blue Yonder offers a unified, AI-driven platform and multi-tier network that empowers businesses to operate sustainably, scale profitably, and delight their customers—all at machine speed. A pioneer in applying AI solutions to the most complicated supply chain challenges, Blue Yonder’s modern innovations and unmatched industry expertise help more than 3,000 retailers, manufacturers, and logistics service providers confidently navigate supply chain complexity and disruption. blueyonder.com

“Blue Yonder” is a trademark or registered trademark of Blue Yonder Group, Inc. Any trade, product or service name referenced in this document using the name “Blue Yonder” is a trademark and/or property of Blue Yonder Group, Inc. All other company and product names may be trademarks, registered trademarks or service marks of the companies with which they are associated.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250923477524/en/

Contacts

Blue Yonder Public Relations Contacts
mediarelationsteam@blueyonder.com
U.S.: +1 480-308-3037
EMEA: +39 335 7849149

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye